ABIONYX Pharma SA Financial Overview
ABIONYX Pharma SA's market cap is currently €123.30M. The company's EPS TTM is €-0.066; its P/E ratio is -26.40; ABIONYX Pharma SA is scheduled to report earnings on September 25, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
